• Return to Headlines

Hot Stock: Trovagene Inc, Shares Gain 5.4% (TROV)

By Amy Schwartz

Trovagene Inc (NASDAQ:TROV) is one of today's best performing penny stocks, up 5.4% to $0.38 on 1.0x average daily volume. Thus far today, Trovagene Inc has traded 565,000 shares, vs. average volume of 551,000 shares per day. The stock has outperformed the Dow (5.4% to the Dow's -100.0%) and outperformed the S&P 500 (5.4% to the S&P's 0.5%) during today's trading.

Trovagene Inc (NASDAQ:TROV) has potential upside of 162.0% based on a current price of $0.38 and analysts' consensus price target of $1.00. Trovagene Inc shares should first meet resistance at the 50-day moving average (MA) of $5.27 and find additional resistance at the 200-day MA of $5.46.

Trovagene, Inc. is an applied genomics company. The Company is developing a non-invasive testing technology using transrenal nucleic acid (TrNA) markers for infectious diseases, prenatal testing, early detection of cancer, monitoring of organ, and cell transplantation.

Over the past year, Trovagene Inc has traded in a range of $0.23 to $5.98 and is now at $0.38, 62% above that low. The 200-day and 50-day moving averages have moved 2.1% lower and 1.58% lower over the past week, respectively.

SmarTrend is tracking the current trend status for Trovagene Inc and will alert subscribers who have TROV in their portfolio or watchlist when shares have changed trend direction.

Keywords: penny stocks trovagene inc

Ticker(s): TROV